Found 160 matching trials
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer PHASE1 This is a single-arm, multicenter, phase II study designed to evaluate the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors PHASE2 QL1706 Combined with Lenvatinib and GEMOX as First - Line Treatment for Unr...
Show More Status
Active Not Recruiting
Location
the Third Affiliated Hospital of Naval Medical University
Learn More & Join Trial
QL1706 Combined With SOX Used in Theperioperative Treatment PHASE1 This is a single-center, single-arm clinical study to evaluate the efficacy...
Show More Location
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Learn More & Join Trial
A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma PHASE2 This is a randomized, open, multicenter phase II/III trial to compare the e...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors PHASE2 This study aims to evaluate the efficacy and safety of QLS31905 and/or QL17...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC PHASE2 Lung cancer is the leading cause of cancer-related deaths worldwide. Accord...
Show More Location
Anhui cancer hospital
Learn More & Join Trial
Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer EARLY_PHASE1 This study investigates the efficacy of neoadjuvant radiotherapy combined w...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy PHASE2 The study is being conducted to evaluation of the Efficacy and Safety of QL...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial